With Democratic presidential candidate Kamala Harris polling neck and neck with former President Donald Trump , Jefferies analysts assessed how her policy positions could result in specific stock reactions across several industry sectors.
Per Jefferies, the Department of Justice and the FTC raised 50 antitrust cases in 2022, which was the highest level since the U.S. initiated pre-merger antitrust reviews in 1976. Pharmaceutical giants Bristol-Myers Squibb , Merck and Pfizer — which frequently make headlines for mergers and acquisitions – may encounter continued scrutiny. Jefferies analysts are bullish on Merck and Pfizer, with buy ratings for both names.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: Investingcom - 🏆 450. / 53 Lire la suite »